Senior Editor, Diagnostic Imaging
Study: AI Improves Cancer Detection Rate for Digital Mammography and Digital Breast Tomosynthesis
March 6th 2023Comparing year-long findings with and without adjunctive artificial intelligence (AI) at a breast cancer screening program in Spain, researchers found the combination of digital breast tomosynthesis and AI had a 92.5 percent accuracy for diagnosing cancer in patients with elevated risk.
Seven Key Considerations with Rectal Cancer MRI
March 3rd 2023In a cum laude awarded presentation at the European Congress of Radiology (ECR), researchers discussed misconceptions and pertinent principles for magnetic resonance imaging (MRI) of patients with rectal cancer, ranging from the diagnosis of mucinous tumors to the impact of mesorectal fascia status for rectal cancer recurrence.
Should Dual-Source CT be the New Standard for ER CCTA Assessment of Acute Chest Pain?
March 3rd 2023Recently published research revealed that coronary computed tomography angiography (CCTA) exams performed with dual-source CT were completed 22 minutes faster and had a nearly 28 percent higher frequency of good or excellent image quality in comparison to CCTA exams performed with single-source CT devices.
Canon Medical Launches New CT and X-Ray Modalities at ECR 2023
March 2nd 2023The new launches include the 80/160-slice computed tomography (CT) scanner Aquilion Serve, which allows simultaneous previews of axial, lateral and AP views, and Celex, a multipurpose X-ray system that offers automated and customizable features to help maximize workflow efficiencies.
New Study Shows Benefits of Prostate Artery Embolization for Men with an Enlarged Prostate
March 1st 2023Prostate artery embolization led to a 32 percent reduction of the prostate gland and a 42 percent decrease in prostate-specific antigen (PSA) values one year after the procedure, according to new research presented recently at the Society of Interventional Radiology (SIR) Annual Scientific Meeting in Phoenix.
Cancer Screenings and COVID-19: What a New Study Shows
February 27th 2023New research from the American Cancer Society comparing pre-pandemic cancer screening prevalence to the second year of the COVID-19 pandemic in the United States showed a 1.1 million decrease in breast cancer screenings, a 4.4 million decrease in cervical cancer screening and a 600,000 decrease in prostate cancer screenings.
AI/CT Combination for Assessing Pulmonary Embolism Severity Gets FDA Nod
February 23rd 2023Facilitating expedited assessment of pulmonary embolism severity, the emerging artificial intelligence (AI) tool Rapid RV/LV reportedly calculates the right ventricle/left ventricle (RV/LV) ratio within minutes of a computed tomography pulmonary angiogram (CTPA).
Can a New AI Tool Improve Detection of Incidental Pulmonary Embolism on CT?
February 22nd 2023Noting that only 25 percent of incidental emboli are identified in reporting of initial computed tomography (CT) exams, Avicenna.AI said the artificial intelligence (AI)-enabled CINA-iPE is geared toward detecting incidental pulmonary embolism (PE) on chest CT scans.
Is Follow-Up Pelvic CT Coverage Necessary for Patients Treated for Hepatocellular Carcinoma?
February 22nd 2023Noting that pelvic coverage can increase radiation dosing for liver computed tomography (CT) by 29 to 39 percent, researchers found low three-year cumulative rates of incidental pelvic tumors and isolated pelvic metastasis in follow-up liver CT imaging of over 1,100 people treated for hepatocellular carcinoma.
Overcoming Burnout in Radiology
February 21st 2023In a recent video interview, radiologist Jonathon Lee, MD, shared insights from his experience on the insidious nature of burnout, emphasized the link between work-life balance and productivity, and discussed a recent partnership between the teleradiology service provider vRad and the behavioral health consultancy VITAL WorkLife to help promote well-being for vRad teleradiologists.
How Accurate is the CT Severity Score for Predicting COVID-19 Severity?
February 17th 2023The computed tomography severity score (CTSS) has sensitivity rates of 85 percent for predicting the severity of COVID-19 and 77 percent for predicting COVID-19 related mortality, according to a newly published meta-analysis.
Recurrent Prostate Cancer and Low PSA Levels: Can an Emerging PSMA PET Agent Have an Impact?
February 16th 2023Use of the prostate-specific membrane antigen (PSMA) positron emission tomography (PET) agent piflufolastat F 18 led to treatment plan changes in nearly 40 percent of men with recurrent prostate cancer and low prostate-specific antigen (PSA) levels, according to new research presented recently at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers (GU) Symposium in San Francisco.
Could Photon Counting CT Supplant MRI for Imaging Assessment of Hepatic Steatosis?
February 16th 2023Preliminary research suggests no significant differences between photon-counting computed tomography (CT) and magnetic resonance imaging (MRI) in the quantification of liver fat fraction in obese patients.
Can an Emerging Radiomics Model Improve CT Angiography Assessment of Heart Attack Risk?
February 14th 2023Derived from coronary computed tomography angiography (CCTA) images, a radiomics model demonstrated a 75 percent or greater area under the curve (AUC) in multiple test sets for identifying vulnerable plaque.
Emerging Trends with AI in Radiology in 2023
February 13th 2023In a recent video interview, Sonia Gupta, MD discussed a number of ongoing developments with artificial intelligence (AI) in radiology, ranging from market consolidation of AI vendors to maximizing automation and efficiency with patient triage, reporting and follow-up of incidental findings.
Can Pre-Op Ultrafast MRI Predict Upgrade of DCIS Lesions to Invasive Breast Cancer?
February 9th 2023In a new study that may have implications for breast cancer surgery, researchers found that shorter time to enhancement (TTE) on preoperative ultrafast magnetic resonance imaging (MRI) was significantly associated with escalation of ductal carcinoma in situ (DCIS) to invasive breast cancer.
Study: AI More Than Doubles the Sensitivity Rate for Lung-RADS Category 4 Nodules on Chest X-Rays
February 7th 2023In newly published research, researchers found that an artificial intelligence (AI) computer-aided detection (CAD) system was more than twice as likely as non-AI assessment to diagnose actionable lung nodules on chest X-rays.
Interval Breast Cancer: What a New Mammography Study Reveals
February 6th 2023In a new study of 1,232 women diagnosed with breast cancer within a year of a screening mammography exam, researchers found that interval breast cancer was 17 percent more likely in women with dense or extremely dense breasts, and over three times more likely to involve stage 2 or higher primary tumors in comparison to screening-detected breast cancer.
Can MRI Surveillance Have an Impact in Detecting Recurrence of Soft Tissue Sarcomas?
February 3rd 2023While acknowledging a moderate to high risk of bias in the retrospective studies reviewed for a recent meta-analysis, researchers found the current evidence supports the use of high-intensity magnetic resonance imaging (MRI) surveillance for detection of soft tissue sarcoma recurrence.